BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19736231)

  • 1. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration.
    Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas.
    Heberer T; Reddersen K; Mechlinski A
    Water Sci Technol; 2002; 46(3):81-8. PubMed ID: 12227607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
    Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
    Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of pharmaceuticals during indirect potable reuse.
    Drewes JE; Heberer T; Reddersen K
    Water Sci Technol; 2002; 46(3):73-80. PubMed ID: 12227606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Environ Pollut; 2009 Jun; 157(6):1778-86. PubMed ID: 19299056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit drugs in the environment.
    Zuccato E; Castiglioni S
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3965-78. PubMed ID: 19736230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant.
    Clara M; Strenn B; Ausserleitner M; Kreuzinger N
    Water Sci Technol; 2004; 50(5):29-36. PubMed ID: 15497826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental aspects of wastewater reclamation.
    Sharma S; Choudhary MP
    J Environ Sci Eng; 2007 Jul; 49(3):235-40. PubMed ID: 18476450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
    Kreuzinger N; Clara M; Strenn B; Kroiss H
    Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
    Daughton CG
    Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater.
    Kreuzinger N; Clara M; Strenn B; Vogel B
    Water Sci Technol; 2004; 50(2):221-8. PubMed ID: 15344795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
    Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
    Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
    Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
    Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
    Strenn B; Clara M; Gans O; Kreuzinger N
    Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.